SEPTInvestingStart Free

OVID 424B3: Secondary offering

Ovid Therapeutics

Filed with the SEC on · accession 0001193125-26-182352

OVID filed a 424B3 (prospectus (offering)) with the SEC on Apr 27, 2026. Ovid Therapeutics filed a prospectus for the resale of up to 29,856,031 shares of common stock by selling stockholders, including shares issuable upon exercise of pre-funded warrants, from a private placement that closed on March 19, 2026. The stock moved +3.5% by the first close after the filing.

Summary of the filing

Ovid Therapeutics filed a prospectus for the resale of up to 29,856,031 shares of common stock by selling stockholders, including shares issuable upon exercise of pre-funded warrants, from a private placement that closed on March 19, 2026. The company will not receive any proceeds from the sale of shares by selling stockholders.

For details, click here →How to read a 424B3 →

Key details

Shares of common stock registered for resale$29.9M
Last reported sale price of common stock$3
IssuerOvid Therapeutics Inc.

How OVID stock reacted

Close before

$2.60

Apr 24, 2026

First close after

+3.46%

$2.69

5 trading days

+7.31%

$2.79

Since filing

+9.62%

$2.85

✦ Ask GOAX AI about this filing — what it means for OVID, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for OVID?

Click here

Frequently asked questions

What did OVID file with the SEC on Apr 27, 2026?

OVID filed a 424B3 (Secondary offering). Ovid Therapeutics filed a prospectus for the resale of up to 29,856,031 shares of common stock by selling stockholders, including shares issuable upon exercise of pre-funded warrants, from a private placement that closed on March 19, 2026. The company will not receive any proceeds from the sale of shares by selling stockholders.

What does a secondary offering mean for OVID stock?

New shares dilute existing holders and are often sold at a discount to the market price.

How do I read a 424B3?

The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B3 (prospectus (offering)): The final terms of an offering of shares or bonds.

How did OVID stock react to this filing?

OVID closed at $2.60 before the filing and $2.69 on Apr 27, 2026 (+3.46%). Five trading days later: $2.79 (+7.31%).

Other OVID SEC filings

Get alerts when OVID files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
OVID overviewOVID analysisOVID newsLatest SEC filings